Pancreatic Polypeptide, human [75976-10-2]
P0353
Estimated Purity≥98%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NamePancreatic Polypeptide, human [75976-10-2]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥98%
- FormatSoluble in water (0.7 mg/mL).
- Scientific DescriptionEndogenous peptide, regulates pancreatic cell signaling; Y4 agonist.
- Storage Instruction-20°C
- UNSPSC12352200
References
- Kahleova H, Mari A, Nofrate V, et al. Improvement in bèta-cell function after diet-induced weight loss is associated with decrease in pancreatic polypeptide in subjects with type 2 diabetes. J Diabetes Complications. 2012 Sep-Oct;26(5):442-9. PMID: 22673566. Hankir MK, Parkinson JR, Minnion JS, et al. Peptide YY 3-36 and pancreatic polypeptide differentially regulate hypothalamic neuronal activity in mice in vivo as measured by manganese-enhanced magnetic resonance imaging. J Neuroendocrinol. 2011 Apr;23(4):371-80. PMID: 21251093. Moriya R, Fujikawa T, Ito J, et al. Pancreatic polypeptide enhances colonic muscle contraction and fecal output through neuropeptide Y Y4 receptor in mice. Eur J Pharmacol. 2010 Feb 10;627(1-3):258-64. PMID: 19818748. Liu YL, Semjonous NM, Murphy KG, et al. The effects of pancreatic polypeptide on locomotor activity and food intake in mice. Int J Obes (Lond). 2008 Nov;32(11):1712-5. PMID: 18779824.